population tentative evidence supports mitoxantrone moderately slowing progression disease decreasing rates relapses two years|oppulation tentative evidence supports mitoxantrone moderately slowing progression disease decreasing rates relapses two years
population tentative evidence supports mitoxantrone moderately slowing progression disease decreasing rates relapses two years|population tentative evidence supports mitoxantrone moderately slowing progression disease dereasing rates relapses two years
population tentative evidence supports mitoxantrone moderately slowing progression disease decreasing rates relapses two years|population tentative evidence supports mitoxantrone moderately slowing psogrersion disease decreasing rates relapses two years
population tentative evidence supports mitoxantrone moderately slowing progression disease decreasing rates relapses two years|population tentative evidence supports mitoxantrone moderately slowing eprogression disease decreasing rates relapses two years
population tentative evidence supports mitoxantrone moderately slowing progression disease decreasing rates relapses two years|population tentative evidence supports mitoxantrone moderateply slowing progression disease decreasing rates relapses two years
population tentative evidence supports mitoxantrone moderately slowing progression disease decreasing rates relapses two years|population tentative evidence supports mitoxantrone moderately slowing progression disease decreasing rates relapses wo years
population tentative evidence supports mitoxantrone moderately slowing progression disease decreasing rates relapses two years|population tentative evidence supports mitofxantrone moderately slowing progression disease decreasing rates relapses two years
population tentative evidence supports mitoxantrone moderately slowing progression disease decreasing rates relapses two years|population tentative evidence supports mitoxantrone moderately slowing proression disease decreasing rates relapses two years
population tentative evidence supports mitoxantrone moderately slowing progression disease decreasing rates relapses two years|population tentative evidence supports mitoxantrone moderately slowing progression disease decreasing rates relapses two aeyrs
population tentative evidence supports mitoxantrone moderately slowing progression disease decreasing rates relapses two years|population tentative evidence suports mitoxantrone moderately slowing progression disease decreasing rates relapses two years
